Costa LJ et al, 2019a
« Back to Glossary Index« Back to Glossary Index
Costa LJ, Chhabra S, Godby KN, Medvedova E, Cornell RF, Hall AC, et al. Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone (Dara-KRd) Induction, Autologous Transplantation and Post-Transplant, Response-Adapted, Measurable Residual Disease (MRD)-Based Dara-Krd Consolidation in Patients with Newly Diagnosed Multiple Myeloma (NDMM). Blood. 2019a Nov 13;134(Supplement_1):Abstract #860 [ASH 2019 61st Meeting]. https://ashpublications.org/blood/article/134/Supplement_1/860/427102/Daratumumab-Carfilzomib-Lenalidomide-and?searchresult=1